Anthony M, Calingaert B, McQuay LJ, Andrews E, McGrath L, Rothman KJ, Rivero-Ferrer E. Suicide, suicidal behavior, and mortality rates in patients with psoriasis in England. Presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 30, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):475. doi: 10.1002/pds
Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Arana A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Pharmacoepidemiol Drug Saf. 2008 Oct 1;17(10):1037. doi: 10.1002/pds.1636
Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf. 2006 Dec 1;15(12):861-72.
Arellano FA, Wentworth CE, May C, Verma A, Rivero E, Rothman KJ. Use of prescription Cyclo-Oxygenase 2 Inhibitors (COX-2) and non COX-2 Non-Steroidal Anti-Inflammatory Drugs (NSAID) in a UK population. Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; June 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Sep; 14(Suppl S2):S141. doi: 10.1002/pds.1136
Arellano FA, Wentworth CE, May C, Verma A, Rivero E, Rothman KJ. Use of prescription cyclo-oxigenase 2 inhibitors (COX-2) and non cox-2 non-steroidal anti-inflammatory drugs (NSAIDS) in a UK population. Pharmacoepidemiol Drug Saf. 2005 Jul;14(Suppl 1):S141.